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explanted endografts revealed streptococcus viridans
infection.
Conclusions: This study presents five cases of EVAR
endograft infection from an infectious or inflammatory
condition, leading to AEF formation. This reinforces the
importance of aggressive surveillance and antibiotic pro-
phylaxis for dental and other invasive procedures to prevent
a potentially fatal complication after EVAR.
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Objectives: Complex aortic endografting has emerged
as an alternative to open surgery for pararenal, suprarenal
and thoracoabdominal aneurysms. Definitions of these an-
eurysms vary and are often related to clamp placement.
With the emergence of complex endovascular options for
repair, defining aneurysm morphology based on clamp
placement is now obsolete and a new classification system
should be developed.
Methods: We propose division of the visceral segment
into zones based on the anatomy and location of the
endovascular “seal-zone”:
- Zone 0: below the lowest renal artery
- Zone 1: between renal arteries
- Zone 2: between the upper renal artery and SMA
- Zone 3: between the SMA and CA
- Zone 4: above the CA
We present the results of our case series of complex
endovascular repair based on the above classification.
Results: Between April 2008 and August 2010, 145
EVAR were performed at a regional centre in the UK. We
classified 84 aneurysms as Zone 0, 20 as Zone1/2, 25 as
Zone 3 and 16 as Zone 4. Mean operative times were 5.1,
6.9 and 8.6 hours for Zones 1-2, 3 and 4 respectively.Mean
number of target vessels were 1.75 for zone 1-2 aneurysms,
2.9 for zone 3 and 3.5 for zone 4 aneurysms. Target vessel
patency was 97% for Zone 1-2, 96% for Zone 3 and 89% for
Zone 4. Morbidity in Zone 1-2 was 35% compared to 48%
in Zone 3 and 38% in Zone 4. 30 day mortality was 0% in
Zone 1-2, 16% in Zone 3 and 13% in Zone 4.
Conclusions: Higher seal-zones reflect more complex
procedures with more visceral vessels involved and are
associated with longer operations, more morbidity and
mortality. The proposed seal-zone classification allows for
accurate and reproducible differentiation between aneu-
rysms requiring complex endovascular repair, replacing the
surgical clamp-based classification.
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Objectives: To study the prevalence, growth rate, and
treatment outcomes of abdominal aortic(AAA) and ili-
ac(IA) aneurysms in adult orthotopic heart transplant
(OHT) recipients at a high-volume transplant center.
Methods:Over a 10-year period, adult OHT recipients
who underwent CT scanning pre and post-transplant were
evaluated for AAA and IA aneurysms.
Results: Of the 638 OHT patients, 319 underwent a
CT scan of the abdomen; 32 (10%) with aneurysms were
identified. Patients with ischemic cardiomyopathy (ICM),
who represent 41% of our OHT population, had a signifi-
cantly elevated prevalence (20%) of AAA/IA. The preva-
lence of aneurysm in the non-ICM patients was not ele-
vated when compared to the general population. The mean
AAA and IA diameters were 37  9 and 22  3 mm,
respectively. Serial imaging in 14 patients demonstrated an
infrarenal growth rate of 7 5mm/year. Seven aneurysms,
with a mean diameter of 52 5 mm, underwent repair; six
elective operations (3 endovascular, 3 open) resulted in no
mortality. One patient died after emergent operation for a
mycotic AAA.
Conclusions: This is the largest reported series and the
only using cross-sectional imaging for aortoiliac aneurysms
in OHT patients. We recommend aneurysm screening for
ICM patients prior to heart transplant. Aneurysm growth
rate is greater in transplant patients and surveillance is
indicated, even for small aneurysms. Elective repair resulted
in a similar morbidity and mortality to non-transplant
patients and we recommend managing these patients using
standard aortic aneurysm guidelines.
AAA/IA Incidence by Cardiomyopathy Type
and Location
Patients AI IR I SR
Total 32 (10%) 6 (2%) 19 (6%) 5 (2%) 2 (1%)
Ischemic
Cardiomyopathy 24 (20%) 6 (5%) 14 (12%) 4 (3%) 0
Non-ischemic
cardiomyopathy 8 (4%) 0 5 (3%) 1 (1%) 2 (1%)
AIaortoiliac, IRinfrarenal, Iiliac, SRsuprarenal
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Objectives: While outcome data on open surgery for
chronic mesenteric ischemia (CMI) exists from single-cen-
ters, risk-adjusted population-based data does not exist.
The objective of this study was to report postoperative
30-day outcomes after open surgery for CMI and analyze
the associated risk factors.
Methods: Patients who underwent open surgery for
CMI were identified from the American College of Sur-
geons’ 2007-09 National Surgical Quality Improvement
Program - a multicenter (more than 180 hospitals), pro-
spective database. Multivariate logistic regression was
performed.
Results: In 178 patients, median age was 65 years with
27.0% being males and 88.2% Caucasians. Median body
mass index (BMI) was 22.5 kg/m2. Comorbidities in-
cluded diabetes (14.6%), chronic obstructive pulmonary
disease (19.7%), prior cardiac surgery/coronary interven-
tion (27.0%), hypertension (75.8%), and renal insufficiency
with serum creatinine (Cr) 1.5 mg/dl (5.1%). Median
(upper quartile-lower quartile) intraoperative transfusion
was 1 units (0-2), operative time 266 minutes (203-328),
and hospital length of stay 8 days (6-13). Twelve patients
(6.7%) underwent thromboendarterectomy, 155 (87.1%)
underwent bypass, and 11 (6.2%) underwent both. Major
morbidity andmortality rates were 34.8% and 6.7%, respec-
tively. Graft failure was seen in 4.5% patients. On multivar-
iate analysis, BMI was associated with mortality (OR 1.4;
95% CI- 1.1 to 1.8; p0.009) and elevated PTT was
associated with morbidity (OR 6.6; 95%CI- 1.1 to 38.9;
p0.04).
Conclusions: Morbidity and mortality rates after open
surgery for CMI among the United States population are
comparable to those reported from single-centers. Patients
with higher BMI and elevated PTT are at increased risk for
adverse events after open surgery.
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Objectives: Prehepatice portal vein obstruction is an
important cause of non-cirrhotic portal hypertension. The
major complications of prehepatic portal hypertension
(PPH) include bleeding esophagogastric varices, hyper-
splenism, and bowel ischemia. The aim of this article is to
discuss the outcomes of surgical and endovascular treat-
ment for the complications from PPH.
Methods: From January 2000 to May 2009, 41 pa-
tients with PPH were treated with open surgery or cathe-
ter-directed thrombolysis. Twenty-nine were male and 12
were female. The median age was 20 years (2 to 54 years).
Thirty-nine patients presented with hypersplenism; 37 had
history of gastrointestinal bleeding; 4 patients complained
of new onset of abdominal pain. Portosystemic shunt was
performed in 34 patients, including 23 mesocaval, 8 sple-
norenal, 2 paraumblilical-jugular, and 1 portocaval shunt.
Esophagogastric devascularization was performed in 3.
Four patients with acute portal vein thrombosis were
treated with catheter-directed thrombolysis. Mean follow
up was 23.4 months (2 to 60 months).
Results: In the 34 patients undergoing portosystemic
shunt, no one had recurrent bleeding. All the 3 patients
with esophagogastric devascularization sustained recurrent
variceal bleeding at 8, 13, and 24 months postoperatively.
One of them died, and the other 2 were converted to
mesocaval shunt. Of the 4 patients undergoing thrombol-
ysis, 3 survived without complication; 1 died due to small
bowel infarction secondary to recurrent portal and mesen-
teric vein thrombosis 40 days later. The 30-day mortality
was zero in this group.
Conclusions: Portosystemic shunt is a safe and effec-
tive treatment for bleeding esophagogastric varices and
severe hypersplenism secondary to PPH. It is more reliable
than esophagogastric devascularization. Endovascular
catheter-directed thrombolysis is an alternative treatment
for acute portal and/or mesenteric venous thrombosis;
however, clinical investigation in a large group of patients is
needed.
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